BioCardia, Inc. financial data

Symbol
BCDA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
320 Soquel Way, Sunnyvale, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Tiger X Medical, Inc. (to 10/17/2016), Cardo Medical, Inc. (to 5/25/2011), CLICKNSETTLE COM INC (to 10/20/2008), NAM CORP (to 3/29/2000)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 64.1 % -53.3%
Debt-to-equity -580 % -334%
Return On Equity 1K %
Return On Assets -208 % -12.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.58M shares -78.8%
Common Stock, Shares, Outstanding 4.52M shares -79.1%
Entity Public Float 48M USD +142%
Common Stock, Value, Issued 5K USD -77.3%
Weighted Average Number of Shares Outstanding, Basic 2.83M shares +96.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.13M USD -52.9%
Costs and Expenses 7.84M USD -40.4%
Operating Income (Loss) -7.76M USD +38.3%
Nonoperating Income (Expense) 42K USD -17.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -7.72M USD +38.4%
Earnings Per Share, Basic 2.35 USD/shares +65.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.93M USD +169%
Accounts Receivable, after Allowance for Credit Loss, Current 10K USD -90.4%
Assets, Current 5.06M USD +139%
Property, Plant and Equipment, Net 47K USD -58.8%
Operating Lease, Right-of-Use Asset 993K USD -26.2%
Other Assets, Noncurrent 171K USD 0%
Assets 6.27M USD +67.3%
Accounts Payable, Current 569K USD +12.2%
Accrued Liabilities, Current 28K USD -22.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 2.84M USD -14.7%
Operating Lease, Liability, Noncurrent 674K USD -37.4%
Liabilities 3.51M USD -20.3%
Retained Earnings (Accumulated Deficit) -158M USD -5.14%
Stockholders' Equity Attributable to Parent 2.75M USD
Liabilities and Equity 6.27M USD +67.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.53M USD +40.2%
Net Cash Provided by (Used in) Financing Activities 1.38M USD +2050%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 50M shares -50%
Common Stock, Shares, Issued 4.52M shares -79.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -154K USD +93.9%
Deferred Tax Assets, Valuation Allowance 36.7M USD +8.03%
Deferred Tax Assets, Gross 36.7M USD +8.03%
Operating Lease, Liability 1.05M USD -25.3%
Depreciation 72K USD -10%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.18M USD -29%
Property, Plant and Equipment, Gross 793K USD +0.64%
Operating Lease, Liability, Current 371K USD +15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 514K USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 499K USD +2.89%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 133K USD -49.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 44K USD -91.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 1.68M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 44K USD -91.4%
Operating Lease, Payments 326K USD +7.59%
Additional Paid in Capital 161M USD +7.46%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 19K USD -13.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 749K USD -33.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%